PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype

Elia Guadagno, Michela Vitiello, Paola Francesca, Gaetano Calì, Federica Caponnetto, Daniela Cesselli, Simona Camorani, Giorgio Borrelli, Marialuisa Califano, Paolo Cappabianca, Claudio Arra, Elvira Crescenzi, Laura Cerchia, Maria Laura Del Basso de Caro, Monica Fedele

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal, proneural and neural, among which the mesenchymal and proneural subtypes have the shortest and longest survival, respectively. Here we show that the transcription factor PATZ1 gene is upregulated in gliomas compared to normal brain and, among GBMs, is particularly enriched in the proneural subtype and co-localize with stemness markers. Accordingly, in GBM-derived glioma-initiating stem cells (GSCs) PATZ1 is overexpressed compared to differentiated tumor cells and its expression significantly correlates with the characteristic stem cell capacity to grow as neurospheres in vitro. Interestingly, survival analysis demonstrated that PATZ1 lower levels informed poor prognosis in GBM and, specifically, in the proneural subgroup, suggesting it may serve a role as diagnostic and prognostic biomarker for intra-subtype heterogeneity of proneural GBM. We also show that PATZ1 suppresses the expression of the mesenchyme-inducer CXCR4, and that PATZ1 and CXCR4 are inversely correlated in GSC and proneural GBM. Overall these findings support a central role of PATZ1 in regulating malignancy of GBM.

Original languageEnglish
Pages (from-to)59282-59300
Number of pages19
JournalOncotarget
Volume8
Issue number35
DOIs
Publication statusPublished - 2017

Fingerprint

Glioblastoma
Phenotype
Glioma
Stem Cells
Mesoderm
Survival Analysis
Brain Neoplasms
Neoplasms
Transcription Factors
Biomarkers
Brain
Genes

Keywords

  • Biomarker
  • Glioma
  • Glioma stem cells
  • PATZ1
  • Tumor heterogeneity

ASJC Scopus subject areas

  • Oncology

Cite this

Guadagno, E., Vitiello, M., Francesca, P., Calì, G., Caponnetto, F., Cesselli, D., ... Fedele, M. (2017). PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. Oncotarget, 8(35), 59282-59300. https://doi.org/10.18632/oncotarget.19546

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. / Guadagno, Elia; Vitiello, Michela; Francesca, Paola; Calì, Gaetano; Caponnetto, Federica; Cesselli, Daniela; Camorani, Simona; Borrelli, Giorgio; Califano, Marialuisa; Cappabianca, Paolo; Arra, Claudio; Crescenzi, Elvira; Cerchia, Laura; de Caro, Maria Laura Del Basso; Fedele, Monica.

In: Oncotarget, Vol. 8, No. 35, 2017, p. 59282-59300.

Research output: Contribution to journalArticle

Guadagno, E, Vitiello, M, Francesca, P, Calì, G, Caponnetto, F, Cesselli, D, Camorani, S, Borrelli, G, Califano, M, Cappabianca, P, Arra, C, Crescenzi, E, Cerchia, L, de Caro, MLDB & Fedele, M 2017, 'PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype', Oncotarget, vol. 8, no. 35, pp. 59282-59300. https://doi.org/10.18632/oncotarget.19546
Guadagno, Elia ; Vitiello, Michela ; Francesca, Paola ; Calì, Gaetano ; Caponnetto, Federica ; Cesselli, Daniela ; Camorani, Simona ; Borrelli, Giorgio ; Califano, Marialuisa ; Cappabianca, Paolo ; Arra, Claudio ; Crescenzi, Elvira ; Cerchia, Laura ; de Caro, Maria Laura Del Basso ; Fedele, Monica. / PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. In: Oncotarget. 2017 ; Vol. 8, No. 35. pp. 59282-59300.
@article{1fbb4632bd3f4c98996a508b4b0e1e94,
title = "PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype",
abstract = "Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal, proneural and neural, among which the mesenchymal and proneural subtypes have the shortest and longest survival, respectively. Here we show that the transcription factor PATZ1 gene is upregulated in gliomas compared to normal brain and, among GBMs, is particularly enriched in the proneural subtype and co-localize with stemness markers. Accordingly, in GBM-derived glioma-initiating stem cells (GSCs) PATZ1 is overexpressed compared to differentiated tumor cells and its expression significantly correlates with the characteristic stem cell capacity to grow as neurospheres in vitro. Interestingly, survival analysis demonstrated that PATZ1 lower levels informed poor prognosis in GBM and, specifically, in the proneural subgroup, suggesting it may serve a role as diagnostic and prognostic biomarker for intra-subtype heterogeneity of proneural GBM. We also show that PATZ1 suppresses the expression of the mesenchyme-inducer CXCR4, and that PATZ1 and CXCR4 are inversely correlated in GSC and proneural GBM. Overall these findings support a central role of PATZ1 in regulating malignancy of GBM.",
keywords = "Biomarker, Glioma, Glioma stem cells, PATZ1, Tumor heterogeneity",
author = "Elia Guadagno and Michela Vitiello and Paola Francesca and Gaetano Cal{\`i} and Federica Caponnetto and Daniela Cesselli and Simona Camorani and Giorgio Borrelli and Marialuisa Califano and Paolo Cappabianca and Claudio Arra and Elvira Crescenzi and Laura Cerchia and {de Caro}, {Maria Laura Del Basso} and Monica Fedele",
year = "2017",
doi = "10.18632/oncotarget.19546",
language = "English",
volume = "8",
pages = "59282--59300",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "35",

}

TY - JOUR

T1 - PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype

AU - Guadagno, Elia

AU - Vitiello, Michela

AU - Francesca, Paola

AU - Calì, Gaetano

AU - Caponnetto, Federica

AU - Cesselli, Daniela

AU - Camorani, Simona

AU - Borrelli, Giorgio

AU - Califano, Marialuisa

AU - Cappabianca, Paolo

AU - Arra, Claudio

AU - Crescenzi, Elvira

AU - Cerchia, Laura

AU - de Caro, Maria Laura Del Basso

AU - Fedele, Monica

PY - 2017

Y1 - 2017

N2 - Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal, proneural and neural, among which the mesenchymal and proneural subtypes have the shortest and longest survival, respectively. Here we show that the transcription factor PATZ1 gene is upregulated in gliomas compared to normal brain and, among GBMs, is particularly enriched in the proneural subtype and co-localize with stemness markers. Accordingly, in GBM-derived glioma-initiating stem cells (GSCs) PATZ1 is overexpressed compared to differentiated tumor cells and its expression significantly correlates with the characteristic stem cell capacity to grow as neurospheres in vitro. Interestingly, survival analysis demonstrated that PATZ1 lower levels informed poor prognosis in GBM and, specifically, in the proneural subgroup, suggesting it may serve a role as diagnostic and prognostic biomarker for intra-subtype heterogeneity of proneural GBM. We also show that PATZ1 suppresses the expression of the mesenchyme-inducer CXCR4, and that PATZ1 and CXCR4 are inversely correlated in GSC and proneural GBM. Overall these findings support a central role of PATZ1 in regulating malignancy of GBM.

AB - Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal, proneural and neural, among which the mesenchymal and proneural subtypes have the shortest and longest survival, respectively. Here we show that the transcription factor PATZ1 gene is upregulated in gliomas compared to normal brain and, among GBMs, is particularly enriched in the proneural subtype and co-localize with stemness markers. Accordingly, in GBM-derived glioma-initiating stem cells (GSCs) PATZ1 is overexpressed compared to differentiated tumor cells and its expression significantly correlates with the characteristic stem cell capacity to grow as neurospheres in vitro. Interestingly, survival analysis demonstrated that PATZ1 lower levels informed poor prognosis in GBM and, specifically, in the proneural subgroup, suggesting it may serve a role as diagnostic and prognostic biomarker for intra-subtype heterogeneity of proneural GBM. We also show that PATZ1 suppresses the expression of the mesenchyme-inducer CXCR4, and that PATZ1 and CXCR4 are inversely correlated in GSC and proneural GBM. Overall these findings support a central role of PATZ1 in regulating malignancy of GBM.

KW - Biomarker

KW - Glioma

KW - Glioma stem cells

KW - PATZ1

KW - Tumor heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=85029109963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029109963&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.19546

DO - 10.18632/oncotarget.19546

M3 - Article

VL - 8

SP - 59282

EP - 59300

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 35

ER -